Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism DCN1 inhibitors(Defective cullin neddylation protein 1 inhibitors), UBC12 modulators(ubiquitin conjugating enzyme E2 M modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H20N6S2 |
InChIKeyGXWRXZRJMKEHCS-UHFFFAOYSA-N |
CAS Registry2765547-70-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 01 May 2021 |